All In Biotech

Drug Trial Radar · NCT02384941

Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of LX4211 as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy

Last checked: Nov 20, 2026Latest source record: Feb 12, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 793 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

793

Actual

Start

Mar 2015

Primary completion

Sep 2016

Study completion Feb 2017

Sponsor

Lead sponsor
Lexicon PharmaceuticalsIndustry
Sponsor type
Industry
Collaborators
Sanofi
First posted
Mar 10, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Phase 3 study was intended to demonstrate superiority of either sotagliflozin high dose or low dose versus placebo on glycosylated hemoglobin A1C (A1C) reduction at Week 24 when used as an adjunct in adult participants with type 1 diabetes mellitus (T1D) who have inadequate glycemic control with insulin therapy.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

  • PlaceboDrug

    Placebo once daily, before first meal of the day.

  • SotagliflozinDrug

    Sotagliflozin once daily, before first meal of the day.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in A1C at Week 24Time frame: Baseline to Week 24

Locations

75 sites in 2 countries. Site status is shown where the registry gives one.

  • Lexicon Investigational Site

    Birmingham, Alabama

  • Lexicon Investigational Site

    Little Rock, Arkansas

  • Lexicon Investigational Site

    Escondido, California

  • Lexicon Investigational Site

    Greenbrae, California

  • Lexicon Investigational Site

    Huntington Beach, California

  • Lexicon Investigational Site

    La Jolla, California

  • Lexicon Investigational Site

    Los Angeles, California

  • Lexicon Investigational Site

    Orange, California

  • Lexicon Investigational Site

    Palm Springs, California

  • Lexicon Investigational Site

    San Mateo, California

  • Lexicon Investigational Site

    Tarzana, California

  • Lexicon Investigational Site

    Tustin, California

  • Lexicon Investigational Site

    Walnut Creek, California

  • Lexicon Investigational Site

    Aurora, Colorado

  • Lexicon Investigational Site

    Longmont, Colorado

  • Lexicon Investigational Site

    Fleming Island, Florida

  • Lexicon Investigational Site

    Jacksonville, Florida

  • Lexicon Investigational Site

    Jacksonville, Florida

  • Lexicon Investigational Site

    New Port Richey, Florida

  • Lexicon Investigational Site

    Ormond Beach, Florida

  • Lexicon Investigational Site

    West Palm Beach, Florida

  • Lexicon Investigational Site

    Atlanta, Georgia

  • Lexicon Investigational Site

    Lawrenceville, Georgia

  • Lexicon Investigational Site

    Roswell, Georgia

  • Lexicon Investigational Site

    Honolulu, Hawaii

  • Lexicon Investigational Site

    Crystal Lake, Illinois

  • Lexicon Investigational Site

    Elgin, Illinois

  • Lexicon Investigational Site

    Springfield, Illinois

  • Lexicon Investigational Site

    Topeka, Kansas

  • Lexicon Investigational Site

    Lexington, Kentucky

  • Lexicon Investigational Site

    Bangor, Maine

  • Lexicon Investigational Site

    Baltimore, Maryland

  • Lexicon Investigational Site

    Boston, Massachusetts

  • Lexicon Investigational Site

    Detroit, Michigan

  • Lexicon Investigational Site

    Chesterfield, Missouri

  • Lexicon Investigational Site

    St Louis, Missouri

  • Lexicon Investigational Site

    Omaha, Nebraska

  • Lexicon Investigational Site

    Henderson, Nevada

  • Lexicon Investigational Site

    Las Vegas, Nevada

  • Lexicon Investigational Site

    Albany, New York

Showing 40 of 75 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.